The Labs Your Doctor Didn't Run (Pre-Protocol Bloodwork Blueprint)

Your doctor checks total testosterone, calls it normal, and sends you home. And for a lot of men, that number sits somewhere in the reference range printed on the lab sheet, which spans from 264 to 916 ng/dL according to a harmonized analysis of over 9,000 men, a range so wide that a man at the bottom and a man at the top are biologically worlds apart, and both get told the same thing.

That is not a diagnosis. That is a starting point that was never followed up on.

To understand why a single number falls short, you need the full chain. Your hypothalamus sends a signal down to your pituitary gland, the pituitary releases hormones called LH and FSH that travel to the testes, and the testes respond by producing testosterone. That testosterone enters the bloodstream, but a significant portion of it immediately gets grabbed by a protein called SHBG, which stands for sex hormone binding globulin, and when testosterone is bound to SHBG it cannot enter your cells and do anything useful. What is left over, the fraction that is not bound, is what your tissues actually have access to.

That whole chain matters because the breakdown can happen anywhere along it.

A man with total testosterone at 600 ng/dL can have less functional testosterone than a man sitting at 400 if the first man has high SHBG capturing most of what he produces. Without measuring SHBG and calculating free testosterone, the 600 looks fine on paper while the man is living with the symptom profile of someone clinically deficient. The number without the context is noise.

LH and FSH add a different layer. If testosterone is low, those two hormones tell you where the problem lives. Low testosterone with high LH and FSH means the brain is shouting and the testes are not responding, which points to a primary problem at the testicular level. Low testosterone with low or normal LH and FSH means the brain is not sending the signal in the first place, which is called secondary hypogonadism and points upstream toward the pituitary or hypothalamus. The Endocrine Society's 2018 guidelines make this distinction the cornerstone of diagnosis because it changes the entire treatment path, and the AUA guideline from the same year recommends measuring LH in every man who presents with low testosterone for exactly this reason.

Without those two numbers, you are guessing at the mechanism.

The full hormonal picture extends further than testosterone. Estradiol matters because testosterone converts to estradiol through a process called aromatization, and estradiol at the wrong level, either too high or too low, produces its own set of problems including water retention, mood changes, and libido disruption. Measuring estradiol in men requires something called LC-MS/MS testing, which is a lab method sensitive enough to accurately detect the lower concentrations found in male physiology, because standard immunoassay tests commonly used for women cross-react with other compounds and produce inaccurate readings in men. Prolactin matters because elevated prolactin actively suppresses LH and FSH secretion, and a prolactin problem will look like a testosterone problem until you check it. Cortisol matters because chronic elevation suppresses the entire reproductive axis from the top down. DHEA-S matters because it gives you a picture of adrenal function that sits adjacent to the whole system.

That is the hormonal map. Then there is the metabolic picture underneath it.

Testosterone and metabolic health are bidirectional. Low testosterone drives insulin resistance, and insulin resistance drives lower testosterone. A standard metabolic panel gives you blood glucose, and most panels stop there, but blood glucose can sit perfectly normal while something called fasting insulin is already elevated, which means the pancreas is producing increasingly large amounts of insulin to force blood sugar into cells that are becoming resistant to its signal. That is insulin resistance developing in real time, and it will not show up on a glucose test until the system is already stressed beyond compensation. Hemoglobin A1c adds a different view, showing you the average blood sugar over the prior three months rather than a single moment in time, and the combination of fasting glucose, fasting insulin, and A1c gives you a picture that no single one of them provides alone.

Cardiovascular markers need the same expansion. A standard lipid panel gives you total cholesterol, LDL, HDL, and triglycerides, but LDL as a calculated number describes the concentration of cholesterol in lipoprotein particles without telling you how many particles are actually present. The particle count is what matters for plaque buildup, and that is measured by something called apolipoprotein B, or ApoB, which directly reflects the number of atherogenic particles in circulation. Two men with identical LDL can have very different ApoB counts and therefore very different cardiovascular risk profiles. High sensitivity C-reactive protein, abbreviated hs-CRP, adds the inflammatory dimension, because arterial plaque is not just a cholesterol story, it is an inflammation story, and hs-CRP tells you whether your cardiovascular system is currently under inflammatory stress.

The safety markers are the last layer, and they become especially relevant if any intervention follows.

Hematocrit, the percentage of your blood volume made up of red blood cells, is one of the most important numbers to establish before starting testosterone therapy, because testosterone stimulates red blood cell production and elevated hematocrit thickens the blood. A 2022 study in the Journal of Urology found that men on testosterone therapy with hematocrit at or above 52 percent had a 35 percent higher risk of major cardiovascular events and venous thromboembolism compared to those with lower hematocrit, which makes the baseline measurement not optional but necessary. A complete blood count gives you that number along with immune markers. A full thyroid panel including TSH, free T3, and free T4 matters because thyroid dysfunction mimics many of the same symptoms as low testosterone and is frequently missed when only TSH is tested. IGF-1 creates a before snapshot if any growth hormone peptides will be part of a protocol, because without knowing where you started, there is no way to measure whether anything is working.

Every number in this panel exists to answer a specific question. SHBG answers why a testosterone number does not match symptoms. LH and FSH answer where in the chain the problem sits. Fasting insulin answers what glucose alone cannot. ApoB answers what LDL obscures. Hematocrit answers what is safe to do next.

The panel is not a formality before starting a protocol. The panel is the reasoning that makes the protocol make sense.

---

References

1. Bhasin S et al. Testosterone Therapy in Men With Hypogonadism. JCEM. 2018 — Endocrine Society guideline: diagnosis requires two fasting morning total T measurements, distinguish primary vs secondary via LH/FSH
2. Mulhall JP et al. Evaluation and Management of Testosterone Deficiency. AUA Guideline. J Urology. 2018 — Total T below 300 ng/dL threshold, recommend LH in all men with low T
3. Travison TG et al. Harmonized Reference Ranges for Circulating Testosterone Levels. JCEM. 2017 — 9,054 men, harmonized range 264-916 ng/dL
4. Ory J et al. Secondary Polycythemia in Men Receiving Testosterone Therapy. J Urology. 2022 — Hematocrit >=52% on TRT = 35% higher MACE/VTE risk (OR 1.35)
5. Rosner W et al. Toward Excellence in Testosterone Testing. JCEM. 2013 — Sensitive LC-MS/MS required for accurate male estradiol

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness